These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 31135716)
21. Role of Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569 [TBL] [Abstract][Full Text] [Related]
22. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438 [TBL] [Abstract][Full Text] [Related]
24. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618 [TBL] [Abstract][Full Text] [Related]
25. The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. Yağci-Küpeli B; Koçyiğit-Deveci E; Adamhasan F; Küpeli S J Pediatr Hematol Oncol; 2019 Aug; 41(6):438-441. PubMed ID: 31033787 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma. Ruggiero A; Lanni V; Librizzi A; Maurizi P; Attinà G; Mastrangelo S; Giordano A; Riccardi R J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679 [TBL] [Abstract][Full Text] [Related]
28. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694 [TBL] [Abstract][Full Text] [Related]
30. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma. Albano D; Bosio G; Bianchetti N; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F Ann Nucl Med; 2019 Jul; 33(7):449-458. PubMed ID: 30929200 [TBL] [Abstract][Full Text] [Related]
31. Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist. Albano D; Bosio G; Tomasini D; Bonù M; Giubbini R; Bertagna F Asia Pac J Clin Oncol; 2020 Oct; 16(5):e207-e215. PubMed ID: 32762133 [TBL] [Abstract][Full Text] [Related]
32. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma. Newman EN; Jones RL; Hawkins DS Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
34. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719 [TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297 [TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma. Dong Y; Zhang X; Wang S; Chen S; Ma C Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974 [TBL] [Abstract][Full Text] [Related]
37. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689 [TBL] [Abstract][Full Text] [Related]
39. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study. Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A; Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534 [TBL] [Abstract][Full Text] [Related]
40. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer. Albano D; Familiari D; Gentile R; Scalisi S; Midiri F; Messina M; Spada M; Fornito MC; Galia M; Midiri M; Alongi P Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]